- Investing Ideas
- /
- Hong Kong Pharmaceuticals & Biotech High Growth Stocks
Hong Kong Pharmaceuticals & Biotech High Growth Stocks
Results
3
0 new
High Growth Stocks
3 companies
WuXi XDC Cayman
Market Cap: HK$44.3b
An investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally.
2268
HK$36.80
7D
-4.0%
1Y
142.4%
Consun Pharmaceutical Group
Market Cap: HK$8.7b
Researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People’s Republic of China.
1681
HK$10.50
7D
6.1%
1Y
57.7%
Essex Bio-Technology
Market Cap: HK$2.9b
An investment holding company, develops, manufactures, and sells biologic drugs in China, Hong Kong, and internationally.
1061
HK$5.06
7D
7.7%
1Y
101.6%